Quote | Ceres Inc. (NASDAQ:CERE)
Last: | $43.40 |
---|---|
Change Percent: | -0.14% |
Open: | $43.5 |
Close: | $43.40 |
High: | $43.53 |
Low: | $43.32 |
Volume: | 1,345,413 |
Last Trade Date Time: | 07/23/2024 03:00:00 am |
News | Ceres Inc. (NASDAQ:CERE)
2024-07-10 10:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-03 12:04:34 ET More on Cerevel Therapeutics Cerevel Therapeutics: Time For A Risk Arbitrage Play? Cerevel Therapeutics gains on report Tempur Sealy will be the subject of FTC meeting (update) Cerevel Therapeutics sinks amid some worry on FTC review of AbbVie ...
Message Board Posts | Ceres Inc. (NASDAQ:CERE)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CERE News Article - Cerevel Therapeutics Reports Second Quarter 2022 Financial Results | whytestocks | investorshangout | 08/01/2022 2:45:57 PM |
whytestocks: $CERE News Article - Cerevel Therapeutics to Present at the Jefferies Healthcare Confer | whytestocks | investorshangout | 05/25/2022 7:30:57 PM |
Back to $20 with another 16,100,000 shares coming | make it happen | investorshub | 06/30/2021 2:02:22 PM |
znewcar1: CERE 136% v83,9M c29.69 f127 H31.09 strong aft | znewcar1 | investorshangout | 06/29/2021 8:10:01 PM |
whytestocks: $CERE News Article - These 2 Nasdaq Biotechs Made Eye-Popping Moves Tuesday | whytestocks | investorshangout | 06/29/2021 6:05:49 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-10 10:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-20 12:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, NY / ACCESSWIRE / May 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Cerevel Therapeutics Holdings, Inc. ("Cerevel") (NASDAQ:CERE) and AbbVie, Inc. ("AbbVie") (NYSE:ABBV). Investors who purchased Cerevel and continue to holdto the present are enco...